Search for: "NOVARTIS PHARMACEUTICALS CORP."
Results 281 - 300
of 367
Sort by Relevance
|
Sort by Date
22 Oct 2009, 4:05 pm
Stevens, 57, of Missoula filed suit against Novartis Pharmaceuticals Corp., alleging the company should have disclosed health risks associated with the bone-strengthening drug called Zometa. [read post]
20 Oct 2009, 8:26 am
Stevens is a Montana woman who allegedly developed osteonecrosis of the jaw (ONJ) due to her use of Zometa and, in turn, sued the drug's maker, Novartis Pharmaceuticals Corp., for failure to warn adequately about that particular side effect. [read post]
19 Oct 2009, 8:03 am
Stevens of Missoula filed suit against Novartis Pharmaceuticals Corp. last year, alleging the company was professionally negligent when it failed to disclose health risks associated with one of its medications. [read post]
19 Oct 2009, 8:03 am
Stevens of Missoula filed suit against Novartis Pharmaceuticals Corp. last year, alleging the company was professionally negligent when it failed to disclose health risks associated with one of its medications. [read post]
1 Oct 2009, 2:14 am
Novartis Pharmaceuticals Corp., 2007 WL 1521138 (D.N.J. [read post]
2 Sep 2009, 11:22 pm
Novartis Corp., 378 F. [read post]
30 Aug 2009, 10:00 pm
Novartis Pharmaceuticals Corp., No. 09-1087 (RBK/KMW), 2009 WL 2496518 (D.N.J. [read post]
28 Aug 2009, 4:13 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471 (S.D.Ohio). [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
14 Aug 2009, 1:04 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
6 Aug 2009, 6:50 am
Novartis Pharmaceuticals Corp., 2009 WL 2230471, at *7 (S.D. [read post]
2 Aug 2009, 10:00 pm
Novartis Pharmaceuticals Corp., No. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram)… [read post]
25 Jun 2009, 4:29 am
Novartis Pharmaceuticals Corp., 541 F. [read post]
27 May 2009, 5:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Pfizer acquires rights to 55 generic pills, 20 injectibles through new deals with Claris Lifesciences and Aurobindo (GenericsWeb) Sytrinol (Polymethoxylated flavones, tocotrienols) – US: District Court N D Illinois rules patent co-owned by US not immunised from infringement or validity determinations (Patent Docs) General… [read post]
26 May 2009, 9:54 am
The companies agreeing to the Alabama settlement are: Abbott Laboratories, Schering-Plough Corp., Warrick Pharmaceuticals Corp., TEVA Pharmaceuticals USA, IVAX Corp., IVAX Pharmaceuticals, Barr Laboratories, Aventis Pharmaceuticals, Aventis Behring, ZLB Behring, Sanofi-Synthelabo, Forest Laboratories, Forest Pharmaceuticals, Baxter Healthcare Corp. and Baxter International. [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
5 May 2009, 9:26 pm
District Court for the District of New Jersey denied Novartis Pharmaceutical Corp.'s request for a jury trial in its suit against Roxane Laboratories Inc. [read post]
21 Apr 2009, 8:45 am
Schering Corp., No. 3:07cv233 (U.S. [read post]
